Capillaroscopic findings and vascular biomarkers in systemic sclerosis: Association of low CD40L levels with late scleroderma pattern

Microvasc Res. 2016 Nov:108:17-21. doi: 10.1016/j.mvr.2016.07.002. Epub 2016 Jul 5.

Abstract

Objective: To determine the relationship between vascular biomarkers reflecting the vascular injury and neoangiogenesis with capillaroscopic changes in systemic sclerosis (SSc).

Methods: Nailfold video-capillaroscopy (NVC) was performed qualitatively (early, active and late scleroderma patterns) in 72 SSc patients (66 female) fulfilling ACR/EULAR (2013) criteria. Serum samples of patients were collected and analysed by flow cytometer with multiplex kits of sCD40L, tPA, MCP-1, sE-selectin, IL-8, IL-6, VEGF, sP-selectin, TGF-β1 and VCAM at the same time with NVC.

Results: Compared to healthy subjects; tPA (p=0.02), MCP-1 (p=0.001), sE-selectin (p=0.008) and TGF-β1 (p=0.001) levels were significantly higher, however sP-selectin (p=0.011) and IL-8 (p=0.001) levels were lower in SSc patients. SSc patients were defined according to NVC patterns as 'early' (n=10), 'active' (n=37) and 'late' (n=25). According to NVC patterns of SSc patients, only sCD40L levels were significantly lower in the 'late' group (p=0.039). The other markers were similar among NVC groups.

Conclusions: NVC is a useful method for investigating the vascular pathogenesis and severity of SSc. Although the levels were similar to healthy controls in patients with early/active NVC patterns, there were lower sCD40L serum levels in patients with late NVC pattern. CD40L may have a role in the early/active phase of vascular involvement.

Keywords: Capillaroscopy; Systemic sclerosis; sCD40L.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • CD40 Ligand / blood*
  • Capillaries / pathology*
  • Case-Control Studies
  • Disease Progression
  • Female
  • Flow Cytometry
  • Humans
  • Male
  • Microscopic Angioscopy*
  • Middle Aged
  • Nails / blood supply*
  • Predictive Value of Tests
  • Prognosis
  • Scleroderma, Systemic / blood
  • Scleroderma, Systemic / diagnosis*
  • Scleroderma, Systemic / pathology
  • Severity of Illness Index

Substances

  • Biomarkers
  • CD40 Ligand